Phillips Andrew John
Insider CIK 1921956 · OKUR Director · ELVN Director · MLTX Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| OKUR OnKure Therapeutics, Inc. | A Award deriv | 2026-08-07 | 2026-08-11 | 22,350 | — | $0 | 22,350 | SEC↗ |
| OKUR OnKure Therapeutics, Inc. | A Award deriv | 2026-08-07 | 2026-08-11 | 22,350 | — | $0 | 22,350 | SEC↗ |
| MLTX MoonLake Immunotherapeutic | A Award deriv | 2026-06-17 | 2026-06-18 | 22,195 | — | $0 | 22,195 | SEC↗ |
| OKUR OnKure Therapeutics, Inc. | A Award deriv | 2026-06-04 | 2026-06-08 | 7,650 | — | $0 | 7,650 | SEC↗ |
| MLTX MoonLake Immunotherapeutic | A Award deriv | 2025-06-05 | 2025-06-09 | 6,682 | — | $0 | 6,682 | SEC↗ |
| OKUR OnKure Therapeutics, Inc. | A Award deriv | 2025-05-28 | 2025-05-30 | 7,650 | — | $0 | 7,650 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | A Award deriv | 2025-02-06 | 2025-02-10 | 20,491 | — | $0 | 20,491 | SEC↗ |
| OKUR OnKure Therapeutics, Inc. | A Award deriv | 2024-10-04 | 2024-10-08 | 15,300 | — | $0 | 15,300 | SEC↗ |
| MLTX MoonLake Immunotherapeutic | A Award deriv | 2024-06-06 | 2024-06-07 | 7,688 | — | $0 | 7,688 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | A Award deriv | 2024-02-13 | 2024-02-15 | 16,835 | — | $0 | 16,835 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | A Award deriv | 2024-02-13 | 2024-02-20 | 23,364 | — | $0 | 23,364 | SEC↗ |
| MLTX MoonLake Immunotherapeutic | A Award deriv | 2023-06-08 | 2023-06-12 | 11,297 | — | $0 | 11,297 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | A Award deriv | 2023-02-23 | 2023-04-06 | 27,567 | — | $0 | 27,567 | SEC↗ |
| MLTX MoonLake Immunotherapeutic | A Award deriv | 2022-04-06 | 2022-05-05 | 45,000 | — | $0 | 45,000 | SEC↗ |